Alnylam Pharmaceuticals, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| DUL.F | IONS | ARWR | BBIO | ROIV | 6855.HK | |
|---|---|---|---|---|---|---|
| Market cap | 26.94B | 7.36B | 8.31B | 13.24B | 26.58B | 10.65B |
| P/E (TTM) | 39.0 | — | — | — | — | — |
| Forward P/E | -53.5 | -38.6 | -11.8 | -301.6 | -21.4 | -73.5 |
| Price/book | 22.3 | 16.7 | 17.8 | -5.3 | 6.3 | 16.3 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −49.01% | −38.08% | +57.54% | +25.89% | +103.09% | −52.27% |
| Today | 0.00% | −2.49% | −0.14% | +0.28% | +5.38% | −8.83% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All DUL.F news ›34,533 Alnylam Pharmaceuticals, Inc. $ALNY Shares Sold by Curated Wealth Partners LLC
Posted by Defense World Staff on Oct 18th, 2026 Read Our Latest Research Report on ALNY Alnylam Pharmaceuticals, Inc is a biopharmaceutical company focused on developing and commercializing medicines based on RNA interference (RNAi), a…
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Stock Rated “Moderate Buy” by Sell-Side Analysts
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the firm, Marketbeat reports.
Alnylam Pharmaceuticals, Inc. $ALNY Shares Newly Acquired by First Citizens Bank & Trust Co.
Posted by Defense World Staff on Oct 17th, 2026 First Citizens Bank & Trust Co. bought a new position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) during the 3rd quarter, according to its most recent disclosure with the…
Wells Fargo & Company Has Lowered Expectations for Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price
Posted by Michael Walen on Oct 14th, 2026 View Our Latest Analysis on Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc is a biopharmaceutical company focused on developing and commercializing medicines based on RNA interference (RNAi),…
Head-To-Head Review: Novavax (NASDAQ:NVAX) & Alnylam Pharmaceuticals (NASDAQ:ALNY)
Posted by Mitch Edgeman on Oct 11th, 2026 Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) and Novavax (NASDAQ:NVAX – Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two businesses…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
themarketsdaily.com4
-
defenseworld.net2
-
wboc.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.